Hatch Biofund

Overview

Hatch Biofund is a life sciences venture capital firm headquartered in the Philadelphia region, one of the fastest-growing biotech hubs in the world. The firm provides early-stage capital to promising life science companies, along with access to deep industry expertise and physical platforms to help them realize their missions. Hatch Biofund emphasizes collaboration, aiming to deliver key support to exceptional entrepreneurs working on life-changing scientific solutions. The firm's investment strategy focuses on sectors such as biotechnology, healthcare, pharmaceuticals, medical devices, diagnostics, and other life sciences industries. Hatch Biofund invests across various stages, including seed, early stage, Series A, Series B, growth, and late stage, with investment sizes ranging from $1 million to $50 million. The firm's geographical focus is primarily on the United States. Hatch Biofund's portfolio includes companies in biotechnology, healthcare, pharmaceuticals, medical devices, diagnostics, and other life sciences sectors. The firm is committed to supporting innovative companies that are developing transformative technologies and solutions in the life sciences industry. By providing both capital and strategic support, Hatch Biofund aims to accelerate the growth and success of its portfolio companies, contributing to advancements in healthcare and life sciences.